Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for VARENICLINE
- Project HOPES: Healthy Options for Pain and Ending Smoking. A Program for Cancer Survivors.
- Concurrent vs. Sequential Cessation of Dual Cigarette and E-cigarette Use
- Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 1
- V+PSF-M for Tobacco Cessation in HIV Care in India
- Switching to E-cigarettes in African-American Smokers
- Nasal Spray Study in Sjogren's Dry Eye Disease
- Botswana Smoking and Abstinence Reinforcement Trial
- Trial of a Harm Reduction Strategy for People With HIV Who Smoke Cigarettes
- Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of OC-01 in Adult Chinese With Dry Eye Disease
- Varenicline for Treatment of E-cigarette Dependence
- A Randomized, Controlled, Double-masked, Investigator-initiated Trial to Evaluate Tear Film Quality and Stability in Subjects With Dry Eye Disease Using OC-01 (Varenicline Solution) Nasal Spray 0.03 mg as Compared to Vehicle Control Nasal Spray
- Evaluating Smoking Cessation Interventions for PWH in South Africa
- Clinical Trial to Evaluate the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease
- Varenicline for Nicotine Vaping Cessation in Adolescents
- Varenicline for the Treatment of Cannabis and Tobacco Use Disorders in Veterans
- OC-01 (Varenicline) Nasal Spray and Dry Eye Signs and Symptoms in Daily Disposable Contact Lens Wearers
- IIT Assessing OC-01Nasal Spray on Symptoms of DED Following CXL
- Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease Following Laser-assisted in Situ Keratomileusis (LASIK)
- Efficacy of Centanafadine SR as a Potential Smoking Cessation Treatment
- Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease Following Photorefractive Keratectomy (PRK)
- Phase 2 Clinical Trial to Evaluate OC-01 Nasal Spray in Subjects With Neurotrophic Keratopathy
- Wellness Intervention for Smoking and HIV
- Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use
- Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment
- A Clinical Trial to Compare Pharmacokinetics of the "CDFF0318" and "Champix Tab. 1mg"
- Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial
- Varenicline For Vaping Cessation In Non Smoker Vaper Adolescents
- Varenicline for Co-occurring Cannabis and Tobacco Use
- Metabolism Informed Smoking Treatment: The MIST RCT
- STARS (Smoking Treatment And Remote Sampling) Study
- A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV
- Financial Incentives for Homeless Smokers: A Community-based RCT
- Investigating N-3 Fatty Acids to Prevent Neonatal Tobacco-related outcomeS
- Crossover Target Engagement Study of Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease (Project #3 - Experiment 3 [UdallP3E3])
- Feasibility of Treatment for Vaping Cessation
- A Novel Human Lab Model for Screening AUD Medications
- Cannabis and Tobacco Co-use Study
- Combination of E-cigarettes and Varenicline for Tobacco Harm Reduction
- Health Systems Reach Interventions Project
- Combining Varenicline and Guanfacine for Smoking Cessation
- Mobile Health Interventions for Medication Adherence Among PLWH
- Cessation Screening Project
- Efficacy and Tolerability of Combination Varenicline With Hydroxyzine as a Potential Smoking Cessation Treatment
- Optimizing Tobacco Use Treatment for PLWHA
- Varenicline and Bupropion for Alcohol Use Disorder
- Mobile Evidence-Based Smoking Cessation for Veterans Living With HIV (MESH)
- Varenicline Light Smoking Pilot
- TOBacco STOP in Chronic Obstructive Pulmonary Disease-Trial - Study Protocol
- Deep rTMS and Varenicline for Smoking Cessation
- Study to Evaluate the Relative Bioavailability of Varenicline Administered as OC-01 (Varenicline) Nasal Spray as Compared to Varenicline Administered Orally as Chantix®
- Evaluating the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray on Dry Eye Disease
- Multimodal Cue Exposure Therapy for Smoking Cessation
- Varenicline Versus Cytisine for Smoking Cessation in Primary Care Setting
- Novel Pharmacotherapy Approaches in Smokers With Serious Mental Illness
- UH3 Varenicline for Cannabis Use Disorder
- Evaluation of the Long Term Follow up of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease
- Individualizing Pharmacotherapy for African American Smokers
- Using Non-invasive Brain Stimulation (tDCS) With Varenicline for Treating Tobacco Dependence
- Comparing the Effectiveness of Combined NRT With Single NRT in Primary Care Clinics in Hong Kong
- Varenicline for Smoking Cessation in Hospitalized Patients With Psychiatric Disorders
- Hollings Cancer Center Varenicline Sampling Study
- Effectiveness of Combination Varenicline and Oral Nicotine Replacement Therapy (COMBO)
- Bronchoscopy in Determining the Effect of E-Cigarette Smoking on Biomarkers in the Lungs
- Randomized Trial of Electronic Cigarettes With or Without Nicotine in Smoking Cessation.
- Varenicline OTC Trial on Efficacy and Safety
- So-Lo-Mo Intervention Applied to the Smoking Cessation Process
- Balanced Placebo Design With Varenicline: Pharmacological and Expectancy Effects on Medication Adherence
- PRecision Interventions for SMoking in the SCCS
- Targeted Pharmacological and Behavioral Treatments for Smoking in Schizophrenia Study 1
- Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
- A Trial of Directly Observed and Long-term Varenicline
- Efficacy of the Use of Genetic Markers in the Choice of the Pharmacological Treatment of Smoking (GENTSMOKE)
- EVarQuit: Extended Pre-quit Varenicline to Assist in Quitting Smoking
- Efficacy and Safety of E-cigarettes for Smoking Cessation in Middle-aged Heavy Smokers
- Smoking Cessation After Acute Coronary Syndrome
- UW Quitting Using Intensive Treatment Study (QUITS)
- Stage Ib Trial of mSMART With Varenicline
- Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer
- Dopamine D2/D3 Receptor Upregulation by Varenicline in Methamphetamine Users
- Human Laboratory Study of Varenicline for Alcohol Use Disorder
- Treating Smokeless Tobacco Use in Rural Veterans
- Combined Bio- and Neuro- Feedback vs. Varenicline Use for Smoking Cessation
- Cytisine Versus Varenicline for Smoking Cessation
- Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease Experiments 1 & 2 - Proj #3
- Smoking Cessation Intervention in Respiratory Inpatients
- Varenicline for "Gradual" vs. "Abrupt" Smoking Cessation in Low-motivated COPD Smokers
- Varenicline Treatment for Cannabis Use Disorder
- Smoking Relapse Prevention Among COPD Ex-smokers
- Varenicline Augmentation of Patch Outcomes in Heavy Drinkers' Smoking Cessation
- Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes
- Smoking Cessation & Opioid Dependence Treatment Integration
- Extended Varenicline Treatment for Smoking Among Cancer Patients
- Studying Partial-agonists for Ethanol and Tobacco Elimination in Russians With HIV (St PETER HIV)
- Effect of Smoking Cessation on Clinical and Microbiological Outcomes of the Non-surgical Periodontal Therapy
- Translational Neuropsychopharmacology Research of Nicotine Addiction
- Combining Varenicline and Naltrexone for Smoking Cessation
- Pre to Postoperative Smoking Cessation
- What Are the Effects of Varenicline Compared With Nicotine Replacement Therapy on Long Term Smoking Cessation and Clinically Important Outcomes?
- UW-CTRI Triple Medication Smoking Cessation Study
- Extended (6-Week) Varenicline Preloading: Does it Facilitate Smoking Reduction and Cessation?
- Cytisine Pharmacokinetics and Dose Response (C-DRAKS 3 and C-DRAKS 4)
- Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
- Varenicline (Chantix) Treatment for Waterpipe Smoking Cessation
- A Smoking Cessation Intervention for Yale Dining Employees
- Effects of Smoking Environments on Craving and Smoking (CameraCue2.0)
- Safety and Efficacity of NFL101 as Tobacco Therapy
- Adaptive Pharmacotherapy for Smoking Cessation
- Effects of Varenicline in Heavy Drinking Smokers
- Varenicline Treatment for Excessive Daytime Sleepiness in Parkinson's Disease
- Optimizing Smoking Cessation for People With HIV/AIDS Who Smoke
- Addressing Post Cessation Weight Gain
- Lorcaserin for Preventing Weight Gain Among Smokers
- Behavioral Activation and Varenicline for Smoking Cessation in Depressed Smokers
- Advancing Tobacco Use Treatment for African American Smokers
- Genetically Informed Smoking Cessation Trial
- Effect of Smoking Reduction on Endothelial Glucocalyx and Vascular Function
- Varenicline and Combined NRT for Smoking Cessation
- Smoking Young Asthmatics: Change of Inflammation During Tobacco Cessation and Steroid Treatment
- Novel Smoking Cessation Drug for Schizophrenia
- Translating Extinction Research to Improve Pharmacotherapy for Tobacco Dependence
- Varenicline + Prazosin for Heavy Drinking Smokers
- Reward Sensitivity and Pharmacotherapy for Smoking Cessation
- New Approaches to Smoking Cessation in Heavy Drinkers
- Pilot Study of Nicotine Nasal Spray and Varenicline on Smoking in Methadone-Maintained Patients
- The MATCH (Medication Aids for Tobacco Cessation and Health) Study
- My Mobile Advice Program: A Randomized Pilot Feasibility Study
- Early In-hospital Initiation of Pharmacotherapy for Smoking Cessation, Patients After ACS
- Optimization of Smoking Cessation Strategies Concurrent With Treatment of Tobacco Related Malignancies
- Study on the Model of Smoking Cessation Intervention and Service Ability Improvement
- Effects of Varenicline on Plasticity in Schizophrenia
- Improving Adherence to Smoking Cessation Medication Among PLWHA
- Dissemination of a Tailored Tobacco Quitline for Rural Veteran Smokers
- Effects of Varenicline on Smoking Lapse in Smokers With and Without Schizophrenia
- Understanding Disparities in Quitting in African American and White Smokers
- Combination Bupropion / Varenicline for Smoking Cessation in Male Smokers
- The Canadian HIV Quit Smoking Trial: Tackling the Co-morbidities of Depression and Cardiovascular Disease in HIV+ Smokers
- Varenicline or Nicotine Patch in Promoting Smoking Cessation Among Current Smokers
- Extended Varenicline Treatment for Smoking Among Cancer Patients
- Varenicline for Nicotine Dependence Among Those With HIV/AIDS
- Efficacy of Varenicline on Smoking Cessation at the Acute Phase of an Exacerbation of Chronic Obstructive Pulmonary Disease
- Zonisamide Augmentation of Varenicline Treatment for Smoking Cessation
- A Phase II Trial of Varenicline for the Treatment of Cocaine Dependence
- Varenicline for Light Smokers
- The Effect of Varenicline on D2/D3 Receptor Binding in Smokers
- Varenicline on Reward Responses and Cognition in Adolescent Smokers
- Reducing Cardiovascular Disease by Combining Smoking Cessation Pharmacotherapy and Behavioural Counseling
- Tailored Tobacco Quitline for Rural Veterans
- Varenicline as a Treatment for Methamphetamine Dependence
- Tailored Smoking Cessation Treatment for LIVE FOR LIFE® Participants
- Varenicline Treatment of Alcohol Dependence in Smokers
- A Comparative Effectiveness & Long Term Health Study in Wisconsin Smokers
- Clinical Trial to Evaluate the Efficacy of Smoking Cessation
- Tobacco Dependence in Breast Cancer Patients Trial of Varenicline (Chantix)
- Smoking Habits and Smoking Cessation in Young Adults
- Brain Nicotine Receptor Density & Response to Nicotine Patch
- Effects of Varenicline on Smoking Reminders
- Varenicline for Adolescent Smoking Cessation
- Sympathovagal Balance in Smoking Cessation
- Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
- Varenicline in Combination With Nicotine Replacement Therapy for Smoking Cessation
- Pilot Study of Varenicline to Treat Opioid Dependence
- Varenicline In-Patient Study
- Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation
- Cognitive Remediation With D-Cycloserine
- Efficacy And Safety Of Smoking Cessation With Varenicline Tartrate In Diabetic Smokers: (DIASMOKE)
- Varenicline Smoking Cessation Treatment for Methadone Maintenance Patients
- A Study To Evaluate The Efficacy And Safety Of Varenicline Compared To Placebo For Smoking Cessation Through Reduction
- Varenicline for Methamphetamine Dependence
- Varenicline Treatment for Active Alcoholic Smokers
- Varenicline for Gait and Balance Impairment in Parkinson Disease
- Smoking Cessation Program in the Preadmission Clinic
- Pharmacogenetics of Nicotine Addiction Treatment
- Smoking Cessation Study In Healthy Adolescent Smokers
- Effect of Varenicline on Tobacco Addiction and on Abstinence-induced Cognitive Impairment
- Varenicline-Aided Cigarette Reduction in Smokers Not Ready to Quit
- Influence of Varenicline on the Antiplatelet Action of Clopidogrel
- Concurrent Bupropion / Varenicline for Smoking Cessation
- Varenicline Pregnancy Cohort Study
- Varenicline in Drug Treatment
- A Multi-National Study To Assess How Effective And Safe The Smoking Cessation Medicine Varenicline Is In Smokers Who Have Already Tried Varenicline In The Past As A Prescription Medicine From Their Usual Healthcare Provider
- A Study Evaluating the Absorption Of Varenicline Through The Skin Following Once Daily Application Of A Patch For 14 Days
- Effectiveness of Varenicline: Testing Individual Differences
- Tailoring Varenicline to Individual Needs (TVIN Study)
- Pilot Study of Tolcapone in Smokers
- Combination of Nicotine Replacement Therapy (NRT) and Varenicline to Increase Cessation of Tobacco (CONVICT Study)
- Safety and Efficacy of the Novel Selective Nicotinic Receptor Partial Agonist, CHANTIX (Varenicline) in Patients With Acute Coronary Syndrome
- Varenicline and Alcohol in Inpatient Addictions Program (IAP)
- Maintaining Nonsmoking
- Human Behavioral Pharmacology Laboratory (HBPL) Study of Varenicline's Impact on Cocaine and Alcohol Craving
- Varenicline for Alcohol Dependence
- Human Behavioral Pharmacology Laboratory Study of Varenicline's Impact on Cocaine Reinforcement
- Smoking Termination Opportunity for inPatients
- Varenicline and Smoking Cessation in Schizophrenia
- "VIBRATIONS" - A Study In Smokers Who Are Willing And Motivated To Stop Smoking With The Aid Of Varenicline Which Will Be Prescribed According To Usual Clinical Practice In Germany
- Smoking Cessation Treatment for Head & Neck Cancer Patients
- Efficacy of Varenicline for Smokeless Tobacco Use in India
- Study of Varenicline (Champix) for Smoking Cessation/Reduction in Patients With Bipolar Disorder
- Effect of Varenicline on Cognitive Function in Cigarette Smokers With Schizophrenia
- Varenicline For Smokers In Recovery From Alcohol Dependence
- Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
- Varenicline for Alcohol Dependence
- Varenicline (Champix®) Special Investigation (Regulatory Post Marketing Commitment Plan)
- Smoking Cessation Treatment for Methadone Maintenance Patients
- Distribution of Bupropion and Varenicline to Increase Smoking Cessation Attempts
- A Study Evaluating The Absorption Of Varenicline Into The Body From A Varenicline Patch Applied To The Skin
- A Pilot Clinical Trial of Varenicline as a Treatment for Alcohol Dependence
- Varenicline vs Placebo for the Treatment of Methamphetamine Dependence
- Varenicline Treatment for Smoking Cessation in Patients With Bipolar Disorder
- Effect of Varenicline on Fixed-Dose Alcohol Administration in Participants With Alcohol Use Disorders
- Efficacy and Safety of NicVAX® Co-administered With Varenicline (Champix®)
- Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3
- Varenicline for Long-term Nicotine Replacement Therapy (NRT) Users
- Efficacy and Cost-Effectiveness of Cost-free Pharmacotherapy for Smoking Cessation for High-risk Smokers With Cerebrovascular Disease
- Varenicline Versus Transdermal Nicotine Patch for Smoking Cessation in Patients With Coronary Heart Disease
- Effects of Chantix on Relapse Prevention for Smoking Cessation
- Measuring Smoking Behaviors While Using Varenicline
- Relapse Prevention With Varenicline
- Combining Varenicline and Bupropion for Smoking Cessation
- Smoking Cessation Program in the Preadmission Clinic
- Treatment of Smoking Among Individuals With PTSD
- Varenicline and Bupropion for Smoking Cessation
- Impact of Varenicline on Blood-Oxygen-Level Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Activation on Smokers
- Smoking Cessation Treatment for Head and Neck Cancer Patients
- Efficacy and Safety of Varenicline Among HIV-infected Patients
- Chantix in Adult Smokers With Attention Deficit Hyperactivity Disorder (ADHD)
- Methadone Maintenance Treatment and Smoking Cessation
- Assessing the Impact of Varenicline on Brain-Behavior Vulnerability
- A Pilot Study Of Smoking Cessation Treatment Including Varenicline In Patients Scheduled For Planned Surgery
- Smoking Study With Behavioral Therapy for Hypertensive Patients
- Effect of Varenicline on Reactivity to Smoking and Drinking Cues
- Varenicline for Smoking Cessation in Heavy Drinking Smokers
- Does Varenicline Influence Alcohol Consumption in Alcohol Dependent Individuals?
- An Alternative Dosing Schedule of Varenicline for Smoking Cessation
- Smoke-Free Living Study
- Long-term Varenicline Treatment for Smoking Cessation
- Varenicline for the Treatment of Smokeless Tobacco
- Varenicline in Bipolar Depressed Patients
- ASIA CHOICES CHampix (Varenicline) Observational Investigation in the CEssation of Smoking
- Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia
- Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors
- Evaluation of Varenicline (Champix) in Smoking Cessation for Patients Post-Acute Coronary Syndrome (EVITA) Trial
- Post Marketing Surveillance Study of Champix in Smoking Cessation for Filipino Patients
- Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking
- Use of Varenicline for 4-weeks Prior to Quitting
- Treating Schizophrenic Smokers: Effects on Craving, Cues and Withdrawal
- Improving Medication Compliance and Smoking Cessation Treatment Outcomes for African American Smokers
- A Study Evaluating The Absorption Of Varenicline Into The Body From A Varenicline Solution And A Varenicline Patch Applied To The Skin
- The Effect of Naltrexone and Varenicline on Alcohol-Mediated Smoking Lapse
- Drug Use Investigation Of Varenicline (Regulatory Post Marketing Commitment Plan)
- Varenicline and Motivational Advice for Smokers With Substance Use Disorders
- Assessing Neuropsychiatric Symptoms Including Depression, Anxiety, Irritability, and Suicidal Thoughts or Behavior in Subjects Quitting Smoking on Varenicline Tartrate or Placebo
- Human Laboratory Study of Varenicline and Bupropion for Nicotine Dependence
- Varenicline Effects on Cue Reactivity and Smoking Reward/Reinforcement
- Evaluation of the Efficacy of Varenicline on Cognition, Safety, Tolerability and Pharmacokinetics in Subjects With Mild-to-Moderate Alzheimer's Disease
- A 6-Week Multicenter Trial Of Varenicline Tartrate For Cognitive Impairment In Subjects With Schizophrenia
- A Study to Evaluate the Safety and Efficacy of Three Doses of a Controlled Release Formulation of Varenicline for Smoking Cessation
- Varenicline-Methamphetamine Interaction Study (2008)
- An Investigation Of The Effects Of Food On The Absorption Of A Varenicline Controlled Release Formulation
- Effects of Varenicline on Cigarette Self Administration
- Varenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophrenia
- Study Evaluating The Efficacy Of Varenicline In Cessation Of Oral Smokeless Tobacco Use
- An Assessment of the Safety of Varenicline in Methamphetamine-dependent Volunteers
- Human Laboratory Study Of Varenicline in Smokers
- Varenicline (Chantix™) for the Treatment of Alcohol Dependence
- Safety and Tolerability of Varenicline in Schizophrenia (SATOVA)
- Smoking Cessation Using Motivational Therapy and Varenicline
- Varenicline to Reduce Alcohol Consumption in Heavy Drinkers
- Evaluation of Varenicline Safety, Tolerability, Pharmacokinetics and Pro-Cognitive Effects in Healthy Elderly Non-Smoking Subjects
- Randomized Study Comparing the Efficacy and Safety of Varenicline Tartrate to Placebo in Smoking Cessation When Subjects Are Allowed to Set Their Own Quit Date
- Contingency Management and Pharmacotherapy for Smoking Cessation
- Endothelial Function and Autonomic Regulation After Short-term Smoking Cessation: Varenicline Versus Placebo
- Varenicline Observational Investigation In The Cessation of Smoking
- Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity
- A Single Dose Study Investigating the Absorption and Elimination as Well as the Tolerability of Varenicline Transdermal Delivery System (e.g., a Patch) as Compared to Oral Varenicline in Adult Smokers.
- Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder
- A Study of the Efficacy and Safety of Varenicline in Japanese Smokers Motivated to Quit Smoking
- A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
- Varenicline and Nicotine Interactions in Humans (VA)
- Effects of Varenicline on Brain Activity During Nicotine Abstinence
- Efficacy of Varenicline in Ambivalent Smokers
- Assessment of Safety and Efficacy of Varenicline in Patients That Wish to Stop Smoking
- Chantix & Bupropion for Smoking Cessation
- The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior
- Do Treatments for Smoking Cessation Affect Alcohol Drinking?
- Smoking Cessation Intervention for Thoracic Patients
- Study of Varencline Effects on Cigarette Smoking Reward and Craving During a Model of Brief Quit Attempt
- Efficacy of Varenicline in Methadone-Stabilized Cocaine Users
- Chantix for Treating Cocaine Dependence
- Comparison of Varenicline and Placebo for Smoking Cessation in Schizophrenia
- Varenicline Effects In Schizophrenic Smokers
- Multiple Dose, Dose Escalation Study of Varenicline Controlled Release Formulation in Adult Smokers
- Mood and Anti-craving Effects of Varenicline in Psychiatric Inpatients
- Study of Mood Effects of Varenicline (Chantix) in Depressed Outpatient Smokers
- The Effects of Varenicline on Cognitive Function in Patients With Schizophrenia
- Pharmacogenetics, Emotional Reactivity and Smoking
- Naltrexone and Varenicline: Weight Gain and Tolerability in Cigarette Smokers
- Varenicline Adjunctive Treatment in Schizophrenia
- Post Marketing Surveillance Study To Observe Safety And Efficacy Of Champix® Tablets
- A Phase I Study to Evaluate the Pharmacokinetics of Multiple Doses of Varenicline in Healthy Adolescent Smokers
- Study of the Effects of Mecamylamine and Varenicline in Schizophrenia
- Phase 1 Clinical Trial of Varenicline in Chinese Healthy Smoking Volunteers
- An Investigation of Effectiveness and Safety of Varenicline Tartrate in Helping People Quit Smoking
- Varenicline Tartrate With Telephone-Based Counseling and/or Internet-Based Counseling in Helping Adults Stop Smoking
- Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).
- Efficacy and Safety of Varenicline in Smokers With Cardiovascular Disease Who Wish to Quit Smoking
- A Seven-Week Dose-Ranging Study of CP-526,555 Compared With Placebo and Zyban for Smoking Cessation
- A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation
- An Open Label Study That Compares Varenicline to Transdermal Nicotine Patch for Smoking Cessation
- A 52-Week Placebo-Controlled Study Evaluating the Safety of Varenicline
- A 52-Week Multicenter Study Evaluating the Safety and Efficacy of Varenicline for the Maintenance of Smoking Cessation
- A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation
- A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo for Smoking Cessation
Clinical trials list
click for details